| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.3 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.055 | 0.3 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |